Transaction in Own Shares

Summary by AI BETAClose X

Fevertree Drinks plc has announced the purchase of 173,000 ordinary shares between July 20th and July 24th, 2026, as part of its share buyback program. The weighted average purchase price across these transactions was approximately 830.74 pence per share, with individual trades ranging from 805.50 pence to 859.50 pence. The company intends to cancel these repurchased shares.

Disclaimer*

Fevertree Drinks PLC
28 July 2026
 

28th July 2026                         

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has, in accordance with the authority granted by shareholders at its 2025 Annual General Meeting held on 5th June, purchased the following number of ordinary shares of £0.0025 each in the Company (the "Ordinary Shares") through the Company's broker, Investec Bank plc ("Investec") in the period from 20th July to 24th July 2026.

Date

Venue

Volume-weighted average price (p)

Aggregated volume

Lowest price per share (p)

Highest price per share (p)

20 July 2026

XLON

812.6423

30,032

805.5000

818.0000

20 July 2026

AIMX

814.0000

25,000

814.0000

814.0000

21 July 2026

XLON

832.1948

15,760

812.0000

845.5000

22 July 2026

XLON

856.1345

10,150

849.0000

859.5000

22 July 2026

AIMX

852.0000

10,000

852.0000

852.0000

23 July 2026

XLON

845.5008

30,832

833.0000

854.0000

23 July 2026

AIMX

837.0000

22,109

837.0000

837.0000

24 July 2026

XLON

820.4697

10,416

813.0000

833.0000

24 July 2026

AIMX

819.0000

29,282

819.0000

819.0000

 

The Company intends to cancel the purchased shares.

   

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation) (which forms part of domestic UK law by virtue of the European Union (Withdrawal) Act 2018, as amended), a full breakdown of the individual trades made by Investec on behalf of the Company as part of the share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/9655N_1-2026-7-27.pdf

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I +44 (0)770 332 9024  

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings